Back to Search
DR. HENRY L GOMEZ M.D.
M.D.
Pediatrics Physician
NPI: 1518994250Individual
Specialties, Licenses & Credentials
Pediatrics PhysicianPrimary
Pediatrics
Code: 208000000X
E1534(AR)
Research & Publications (20)
A new assay for the detection of Loxosceles species (brown recluse) spider venom.
PMID 11973553·Ann Emerg Med·2002
4-observational
Lactoferrin protects rabbits from Shigella flexneri-induced inflammatory enteritis.
PMID 12438385·Infect Immun·2002
7-preclinical
Antigenic cross-reactivity of venoms from medically important North American Loxosceles spider species.
PMID 11137541·Toxicon·2001
7-preclinical
A phase II study of neoadjuvant gemcitabine plus doxorubicin in stage IIIB breast cancer: a preliminary report.
PMID 11510035·Semin Oncol·2001
3-trial
Direct correlation between diffusion of Loxosceles reclusa venom and extent of dermal inflammation.
PMID 11282664·Acad Emerg Med·2001
4-observational
Protective role of human lactoferrin against invasion of Shigella flexneri M90T.
PMID 11787716·Adv Exp Med Biol·2001
8-other
Targeted therapies: Combined lapatinib and paclitaxel in HER2-positive breast cancer.
PMID 19483734·Nat Rev Clin Oncol·2009
8-other
Influence of obesity on cancer-related outcomes after pancreatectomy to treat pancreatic adenocarcinoma.
PMID 19289659·Arch Surg·2009
8-other
Analysis of dermatologic events in patients with cancer treated with lapatinib.
PMID 18600445·Breast Cancer Res Treat·2009
6-review
Development of an integrated biospecimen bank and multidisciplinary clinical database for pancreatic cancer.
PMID 18256882·Ann Surg Oncol·2008
8-other
Efficacy and safety of lapatinib as first-line therapy for ErbB2-amplified locally advanced or metastatic breast cancer.
PMID 18458039·J Clin Oncol·2008
3-trial
PIK3CA-activating mutations and chemotherapy sensitivity in stage II-III breast cancer.
PMID 18371219·Breast Cancer Res·2008
8-other
Treatment of advanced hormone-sensitive breast cancer in postmenopausal women with exemestane alone or in combination with celecoxib.
PMID 18323548·J Clin Oncol·2008
3-trial
Phase III, double-blind, randomized study comparing lapatinib plus paclitaxel with placebo plus paclitaxel as first-line treatment for metastatic breast cancer.
PMID 18955454·J Clin Oncol·2008
3-trial
Determination of oestrogen-receptor status and ERBB2 status of breast carcinoma: a gene-expression profiling study.
PMID 17329190·Lancet Oncol·2007
8-other
Diagnosis of loxoscelism in two Turkish patients confirmed with an enzyme-linked immunosorbent assay (ELISA) and non-invasive tissue sampling.
PMID 17498430·Dermatol Online J·2007
5-case
CYP2D6*4 polymorphism is associated with statin-induced muscle effects.
PMID 17700359·Pharmacogenet Genomics·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via CROSSETT HEALTH FOUNDATION · 2 locations total
- Address
- 1003 FRED LAGRONE DR
CROSSETT, AR 71635 - Phone
- (870) 364-3800
Quick Facts
- NPI
- 1518994250
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 2
- Publications
- 20
Are you this provider?
Claim Your Profile